PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1386
https://www.valueinhealthjournal.com/article/S1098-3015(12)03099-9/fulltext
Title :
PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03099-9&doi=10.1016/j.jval.2012.08.1386
First page :
A444
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
882